Company intelligence / Profile preview
LB Abnoba
Seoul, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
LB Abnoba is a South Korean pharmaceutical company and a key member of the LB Group, specializing in integrative oncology and immune-based therapies. Established in 1999 through a technical partnership with the German firm Abnoba GmbH, the company is the exclusive provider of abnobaVISCUM, a standardized mistletoe extract used as a complementary treatment to enhance the quality of life and immune function in cancer patients. LB Abnoba conducts extensive research into mistletoe-derived compounds and is developing a pipeline that includes liposomal formulations and treatments for chronic conditions such as diabetes and rheumatoid arthritis. The company operates a dedicated research institute and collaborates with global pharmaceutical partners to bring innovative healthcare solutions to the Korean market.
- Therapeutic areas
- ImmunologyWomen's HealthEndocrinologyPsychiatryInfectious DiseasesOncology
- Modalities
- Herbal medicineBiologicProteinPeptidesLiposomeSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Abnoba GmbHDHU (Deutsche Homöopathie-Union)Queisser Pharma
Beyond the preview
Go deeper on LB Abnoba.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LB Abnoba.